Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002107518 | SCV002391048 | likely benign | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002382356 | SCV002672736 | likely benign | Cardiovascular phenotype | 2020-02-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002499960 | SCV002809650 | likely benign | Familial visceral amyloidosis, Ostertag type; Hypoalphalipoproteinemia, primary, 2; Hypoalphalipoproteinemia, primary, 2, intermediate | 2022-04-18 | criteria provided, single submitter | clinical testing |